Table I.

Effect of MCT on hemodynamics and right ventricular weight one week after administration.

Variable	Control	PAH
RVSP (mmHg)	34.38±1.86	50.33±1.39b
MPAP (mmHg)	20.18±2.19	40.28±3.27b
MRVP (mmHg)	19.43±3.17	42.64±4.25b
RV/BW	0.49±0.03	0.57±0.06b

MCT, monocrotaline; PAH, pulmonary arterial hypertension; RVSP, right ventricular systolic pressure; MPAP, mean pulmonary arterial pressure; MRVP, mean right ventricular pressure; RV/BW, ratio of right ventricular to body weight.

^aP<0.05,

^bP<0.01,

^cP<0.001 vs. control.